CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 91 enrolled
Drug / intervention
Minimally invasive coronary artery bypass graft surgeryprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01334866
NCT01334866Phase 4Completed
CompareCT.gov

Graft Patency Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Via Minimally Invasive Coronary Surgery

Medtronic Cardiovascular·interventional·Posted Apr 13, 2011·Updated Nov 26, 2013

In Brief

A Phase 4 clinical trial evaluating Minimally invasive coronary artery bypass graft surgery for Arteriosclerosis of Coronary Artery Bypass Graft. Completed, enrolled 91 participants across 2 sites in 2 countries.

Detailed Summary

This clinical study has been developed to evaluate the clinical outcomes in patients undergoing coronary artery bypass grafting via Minimally Invasive Coronary Surgery (MICS); a minimally invasive coronary bypass procedure that is done on a beating heart via a smaller chest incision, thus avoiding the invasiveness of the standard procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArteriosclerosis of Coronary Artery Bypass Graft
CountriesCanada, United States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 13, 2011
Enrollment StartDec 1, 2009
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 15.2 years ago

Interventions

Minimally invasive coronary artery bypass graft surgeryprocedure

The MICS CABG procedure can bridge the gap between percutaneous coronary intervention (PCI) and standard sternotomy. The key components are direct vision, creating anastomoses with traditional instruments and proximal aortic location.